CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Development Holdings Limited Company Snapshot
Tianjin Development Holdings Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Development Holdings Limited with three other companies in this sector in Hong Kong: CK Life Sciences Intl (Holdings) Inc (2018 sales of 5.23 billion Hong Kong Dollars [US$668.51 million] of which 56% was Health), China Shineway Pharmaceutical Group Limited (3.04 billion Hong Kong Dollars [US$388.70 million] of which 52% was Injections), and China Grand Pharmaceutical and Healthcare Holdings Limited (5.96 billion Hong Kong Dollars [US$761.18 million] of which 60% was Manufacture and sales of pharmaceutical ).

Sales Analysis. During the year ended December of 2018, sales at Tianjin Development Holdings Limited were HK$5.39 billion (US$688.76 million). This is a decrease of 22.8% versus 2017, when the company's sales were HK$6.99 billion. The sales level in 2018 was fairly close to the level five years ago: in 2013, Tianjin Development Holdings Limited had sales of HK$4.95 billion. Contributing to the drop in overall sales was the 62.6% decline in Utilities, from HK$3.87 billion to HK$1.44 billion. . However, these declines were partially offset by the increase in sales of Pharmaceutical (up 37.1% to HK$2.57 billion) and Electrical and Mechanical (up 10.4% to HK$1.24 billion) and Hotels (up 9.4% to HK$127.74 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Development Holdings Limited
  Stock Performance Chart for Tianjin Development Holdings Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 2.21
(Figures in Hong Kong Dollars)
1 Week -1.3%   13 Weeks -1.8%  
4 Weeks 2.3%   52 Weeks -18.1%  
 
Tianjin Development Holdings Limited Key Data:
  Ticker: 882 Country: Hong Kong
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 5,391,500,000
(Year Ending Jan 2019).
Employees: 4,179
  Currency: Hong Kong Dollars Market Cap: 2,370,821,700
  Fiscal Yr Ends: December Shares Outstanding: 1,072,770,000
  Share Type: Ordinary Closely Held Shares: 673,759,143
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.